<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Rao MJ</submitter><funding>Natural Science Foundation of Guangxi Province</funding><funding>National Natural Science Foundation of China</funding><pagination>988249</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9480494</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9</volume><pubmed_abstract>Sugarcane (&lt;i>Saccharum&lt;/i> ssp., Poaceae) provides enormous metabolites such as sugars, lipid, and other dietary metabolites to humans. Among them, lipids are important metabolites that perform various functions and have promising pharmacological value. However, in sugarcane, few studies are focusing on lipidomics and few lipid compounds were reported, and their pharmacological values are not explored yet. The transcriptomic and widely targeted lipidomics approach quantified 134 lipid compounds from the rind of six sugarcane genotypes. These lipid compounds include 57 fatty acids, 30 lysophosphatidylcholines, 23 glycerol esters, 21 lysophosphatidylethanolamines, 2 phosphatidylcholines, and 1 sphingolipid. Among them, 119 compounds were first time reported in sugarcane rind. Seventeen lipi</pubmed_abstract><journal>Frontiers in nutrition</journal><pubmed_title>A high-throughput lipidomics and transcriptomic approach reveals novel compounds from sugarcane linked with promising therapeutic potential against COVID-19.</pubmed_title><pmcid>PMC9480494</pmcid><funding_grant_id>31171524</funding_grant_id><funding_grant_id>31771775</funding_grant_id><funding_grant_id>2020GXNSFDA238027</funding_grant_id><pubmed_authors>Tahir Ul Qamar M</pubmed_authors><pubmed_authors>Duan M</pubmed_authors><pubmed_authors>Ma L</pubmed_authors><pubmed_authors>Wang D</pubmed_authors><pubmed_authors>Ali Q</pubmed_authors><pubmed_authors>Rao MJ</pubmed_authors><pubmed_authors>Hu L</pubmed_authors><pubmed_authors>Han S</pubmed_authors><pubmed_authors>Wang L</pubmed_authors></additional><is_claimable>false</is_claimable><name>A high-throughput lipidomics and transcriptomic approach reveals novel compounds from sugarcane linked with promising therapeutic potential against COVID-19.</name><description>Sugarcane (&lt;i>Saccharum&lt;/i> ssp., Poaceae) provides enormous metabolites such as sugars, lipid, and other dietary metabolites to humans. Among them, lipids are important metabolites that perform various functions and have promising pharmacological value. However, in sugarcane, few studies are focusing on lipidomics and few lipid compounds were reported, and their pharmacological values are not explored yet. The transcriptomic and widely targeted lipidomics approach quantified 134 lipid compounds from the rind of six sugarcane genotypes. These lipid compounds include 57 fatty acids, 30 lysophosphatidylcholines, 23 glycerol esters, 21 lysophosphatidylethanolamines, 2 phosphatidylcholines, and 1 sphingolipid. Among them, 119 compounds were first time reported in sugarcane rind. Seventeen lipi</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2026-04-08T12:11:00.246Z</modification><creation>2024-11-08T09:48:26.26Z</creation></dates><accession>S-EPMC9480494</accession><cross_references><pubmed>36118771</pubmed><doi>10.3389/fnut.2022.988249</doi></cross_references></HashMap>